Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,517 | -5,687 | -36 | -40 | -73 |
| Depreciation Amortization | 101 | 34 | 1 | 1 | 1 |
| Accounts receivable | N/A | N/A | N/A | 2 | -2 |
| Accounts payable and accrued liabilities | 126 | 647 | 9 | 10 | 2 |
| Other Working Capital | 537 | 1,349 | 9 | 11 | 1 |
| Other Operating Activity | -27 | 56 | 9 | 5 | 40 |
| Operating Cash Flow | $-8,780 | $-3,601 | $-9 | $-12 | $-30 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -130 | -275 | N/A | N/A | N/A |
| Investing Cash Flow | $-130 | $-275 | $N/A | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 1 | 4 |
| Debt Repayment | N/A | N/A | -1 | -6 | N/A |
| Common Stock Issued | 5 | 4,500 | 10 | 17 | N/A |
| Other Financing Activity | 16,760 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $16,764 | $4,500 | $9 | $12 | $4 |
| Beginning Cash Position | 1,027 | 402 | 0 | 1 | 27 |
| End Cash Position | 8,881 | 1,027 | 0 | 0 | 1 |
| Net Cash Flow | $7,854 | $624 | $0 | $0 | $-26 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,780 | -3,601 | -9 | -12 | -30 |
| Capital Expenditure | -130 | -275 | N/A | N/A | N/A |
| Free Cash Flow | -8,910 | -3,876 | -9 | -12 | -30 |